New Zealand upgrades WAND database
This article was originally published in Clinica
Executive Summary
New Zealand's devices regulatory agency, Medsafe, yesterday launched an upgraded Web-Assisted Notification of Devices (WAND) system. Among the new features of the system is the ability to specifically notify in vitro diagnostic (IVD) products. New Zealand requires all products to be registered in the database within 30 days of their supply or export; this is set out in the Medicines (Database of Medical Devices) Regulations 2003, which came into force on January 1 2004. Details of how to access WAND, together with user instructions and other New Zealand market regulatory information, is available at: http://www.medsafe.govt.nz/regulatory/wand.asp/
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.